Biosonics is building a new class of biomolecular imaging tools that make it possible to visualise cellular activity deep inside living tissue—non-invasively and in real time. Their technology, NSSM, leverages acoustic reporter genes (ARGs): genetically encoded proteins that produce ultrasound contrast when expressed in cells.

The goal of Breathomix is to bring exhaled breath based diagnosis to medicine in a point of care setting.

CC Diagnostics offers a superior, easily implementable triage test with an unsurpassed specificity and reproducibility, which will decrease the number of misdiagnosed women, decrease healthcare costs, and increase screening participation.

ciPTEC is a human renal cell line that mimics the proximal tubule cells of the kidney. These cells are a main target for drug-induced kidney injury, caused by their role in highly efficient transport of drugs and toxic compounds from the bloodstream into urine. The most relevant drug transporter proteins involved in this process are stably and functionally expressed in our cell models.

Cenya Imaging is a clinical stage company developing medical imaging agents to track cells in patients and measure the biodistribution and pharmacokinetics of cell therapies.

Cergentis’ Targeted Locus Amplification (TLA) technology constitutes a paradigm shift by, uniquely, enabling targeted and complete gene sequencing.

Ceronco is developing new anti-cancer drugs based on the SCS-technology

ChainCraft offers a technological solution to the waste and agro-food industries to produce biochemicals

Chippoids is developing a unique multi-organ-on-chip system of the kidney and liver, for which the researchers use human organoids, and at the same time they are also developing a bloodvessel-on-a-chip.

An organ-on-chip company with patent-protected technology for the mechanical stimulation of human cells, leveraged to develop joint models to study rheumatoid and osteoarthritis, animal free